- Home
- SOFI vs PEN Comparison
SOFI vs PEN Comparison
Compare SOFI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOFI | PEN |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 10.9B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SOFI | PEN |
|---|---|---|
| Price | $27.03 | $312.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 16 |
| Target Price | $24.70 | ★ $311.25 |
| AVG Volume (30 Days) | ★ 65.1M | 487.3K |
| Earning Date | 01-26-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 357.55 | ★ 367.34 |
| EPS | 0.54 | ★ 4.14 |
| Revenue | ★ $3,290,639,000.00 | $1,333,798,000.00 |
| Revenue This Year | $37.00 | $16.77 |
| Revenue Next Year | $27.42 | $14.12 |
| P/E Ratio | ★ $50.32 | $75.25 |
| Revenue Growth | ★ 30.62 | 14.61 |
| 52 Week Low | $8.60 | $221.26 |
| 52 Week High | $32.73 | $315.01 |
Technical Indicators
Market Signals| Indicator | SOFI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 67.99 |
| Support Level | $26.48 | $286.75 |
| Resistance Level | $27.68 | $303.00 |
| Average True Range (ATR) | 1.13 | 8.69 |
| MACD | -0.17 | 0.81 |
| Stochastic Oscillator | 32.84 | 92.00 |
Price Performance
Historical ComparisonAbout SOFI SoFi Technologies Inc.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.